ÈËÆÞÖгöÊÓƵ

Anna Chalmers
Rating: 4.9 of 5
( out of 95 reviews )

Anna Chalmers, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Salt Lake City
801-585-0100

Sugar House ÈËÆÞÖгöÊÓƵ Center

Salt Lake City
801-581-2000

  • Anna Chalmers, M.D. is an Assistant Professor in Division of Oncology and an investigator at the Huntsman Cancer Institute. Dr. Chalmers is a specialist in adult medical oncology, with a focus in sarcoma. She joined the faculty in 2016 and see patients at the Huntsman Cancer Institute in Salt Lake City and Sugarhouse.

    Dr. Chalmers received her bachelor’s degree from Dartmouth College and her medical degree from Drexel ÈËÆÞÖгöÊÓƵ College of Medicine. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Rush ÈËÆÞÖгöÊÓƵ Medical Center in Chicago.

    Dr. Chalmers is actively involved in research. She is committed to utilizing clinical studies to benefit her patients at the Huntsman Cancer Institute. She is a member of several international organizations, including the Connective Tissue Oncology Society and the American Society of Clinical Oncology.

    Dr. Chalmers is a native of Newport Beach, California. She enjoys hiking, sailing, and skiing with her ÈËÆÞÖгöÊÓƵren and husband, who is an orthopedic surgeon at the ÈËÆÞÖгöÊÓƵ of Utah.

    Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 95 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    August 24, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    I really like her. She is knowledgeable and cared about me and my health! She took the time to talk to me, my husband and daughter and we felt comfortable and she didn't appear rushed even though we know she is a very busy doctor. I completely trust her to help us make good decisions for my health.

    August 18, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Excellent Doctor [TRANSLATED]

    August 16, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Chalmers is caring, patient and kind. She takes time to answer all of our questions.

    August 15, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Good communicator and listener.

    July 12, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Chalmers is outstanding, I trust her. She cares. She is very intelligent and perceptive in knowing options for my care.

    July 03, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Chalmers has saved my life. She is intelligent, caring, and listens to my thoughts and concerns. I trust her with my cancer care. treatment.

    June 17, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Chalmers gave me a great deal of confidence in her experience and knowledge. She was through and explained things in a way I understood.

    May 25, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    I am extremely fortunate to have her as my oncologist. She is obviously brilliant and exceptionally well educated. I trust her. She is also compassionate and kind.

    May 23, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Ahhhh my excellent Doctor, very humane and explained my treatment very well. [TRANSLATED]

    See More Patient Comments

  • Anna Chalmers, M.D. is an Assistant Professor in Division of Oncology and an investigator at the Huntsman Cancer Institute. Dr. Chalmers is a specialist in adult medical oncology, with a focus in sarcoma. She joined the faculty in 2016 and see patients at the Huntsman Cancer Institute in Salt Lake City and Sugarhouse.

    Dr. Chalmers received her bachelor’s degree from Dartmouth College and her medical degree from Drexel ÈËÆÞÖгöÊÓƵ College of Medicine. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Rush ÈËÆÞÖгöÊÓƵ Medical Center in Chicago.

    Dr. Chalmers is actively involved in research. She is committed to utilizing clinical studies to benefit her patients at the Huntsman Cancer Institute. She is a member of several international organizations, including the Connective Tissue Oncology Society and the American Society of Clinical Oncology.

    Dr. Chalmers is a native of Newport Beach, California. She enjoys hiking, sailing, and skiing with her ÈËÆÞÖгöÊÓƵren and husband, who is an orthopedic surgeon at the ÈËÆÞÖгöÊÓƵ of Utah.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology and Medical Oncology - Rush ÈËÆÞÖгöÊÓƵ Medical Center Fellow
    Residency Internal Medicine - Rush ÈËÆÞÖгöÊÓƵ Medical Center Resident
    Professional Medical Medicine - Drexel ÈËÆÞÖгöÊÓƵ College of Medicine M.D.
    Undergraduate Dartmouth College B.A.

    Selected Publications

    Journal Article

    1. Puri S, Malani R, Chalmers A, Kerrigan K, Patel SB, Monynahan K, Cannon L, Blouw B, Akerley W (2023). Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide(TM). Neurooncol Adv, 6(1), vdad150. ()
    2. Kerrigan K, Patel SB, Haaland B, Ose D, Weinberg Chalmers A, Haydell T, Meropol NJ, Akerley W (2020). Prognostic Significance of Patient-Reported Outcomes in Cancer. JCO Oncol Pract, 16(4), e313-e323. ()
    3. Chalmers AW, Patel S, Boucher K, Cannon L, Esplin M, Luckart J, Graves N, Van Duren T, Akerley W (2019). Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up. Target Oncol, 14(4), 417-421. ()
    4. Chalmers A, Cannon L, Akerley W (2018). Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib. Oncologist, 24(7), 963-972. ()

    Editorial

    1. Chalmers AW, Patel SB, Akerley W (2018). Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care? J Thorac Dis, 10(3), 1198-1200. ()

    Letter

    1. Chalmers A, Akerley W (2017). Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naïve, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice. [Letter to the editor]. J Clin Oncol, 35(20), 2340. ()

  • News & Podcasts

    Huntsman Cancer Institute News